LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) has announced the appointment of Martin Soeters to its Board of Directors. Mr. Soeters is President of Novo Nordisk, Inc. and Senior Vice President of Novo Nordisk North America. He has been with the company for more than 25 years.
